Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
- PMID: 8329922
- PMCID: PMC1678014
- DOI: 10.1136/bmj.306.6892.1584
Uptake of cystic fibrosis testing in primary care: supply push or demand pull?
Abstract
Objective: To determine the acceptability and feasibility of screening for carriers of cystic fibrosis in a primary care setting.
Design: Follow up study over 15 months of patients offered carrier testing by mouthwash.
Setting: A general practice in inner London.
Subjects: 5529 patients aged 18-45 invited by various methods and combinations of methods (letter, booklet, personal approach) for testing.
Main outcome measures: Uptake of screening, anxiety, and knowledge of test.
Results: 957 (17%) invitees were screened over the 15 months. 28 carriers and no carrier couples were detected. Uptake rates were 12% (59/502 patients) among patients invited by letter and tested by appointment; 9% (47/496) among patients invited by letter, with leaflet, and tested by appointment; 4% (128/2953) among patients invited by letter six weeks before the end of the study and tested by appointment; 17% (81/471) among patients offered passive opportunistic testing; 70% (453/649) among patients offered active opportunistic testing; and 25% (22/88) among patients offered active opportunistic testing by appointment. A short term rise in anxiety among those given a positive test result had dissipated by three months. At three months about one fifth and one third of those given positive and negative results respectively did not understand their results correctly.
Conclusion: These results suggest that the strongest variable in determining uptake of screening is the active approach by a health professional offering immediate testing. It remains to be resolved whether the high uptake rates achieved by active recruitment indicate a supply push for this new test rather than a demand from the population.
Comment in
-
Screening for cystic fibrosis in primary care.BMJ. 1993 Jun 12;306(6892):1558-9. doi: 10.1136/bmj.306.6892.1558. BMJ. 1993. PMID: 8329910 Free PMC article. No abstract available.
Similar articles
-
The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP.J Med Genet. 1997 Jun;34(6):459-64. doi: 10.1136/jmg.34.6.459. J Med Genet. 1997. PMID: 9192264 Free PMC article.
-
The impact of population based screening for carriers of cystic fibrosis.J Med Genet. 1994 May;31(5):364-8. doi: 10.1136/jmg.31.5.364. J Med Genet. 1994. PMID: 8064812 Free PMC article.
-
Cystic fibrosis carrier testing in early pregnancy by general practitioners.BMJ. 1993 Jun 12;306(6892):1580-3. doi: 10.1136/bmj.306.6892.1580. BMJ. 1993. PMID: 8329921 Free PMC article.
-
Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.Genet Med. 2014 Mar;16(3):207-16. doi: 10.1038/gim.2013.125. Epub 2013 Sep 12. Genet Med. 2014. PMID: 24030436
-
Population screening for cystic fibrosis.Curr Opin Pediatr. 1996 Dec;8(6):635-8. doi: 10.1097/00008480-199612000-00016. Curr Opin Pediatr. 1996. PMID: 9018450 Review.
Cited by
-
Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.J Community Genet. 2014 Jan;5(1):13-29. doi: 10.1007/s12687-012-0131-z. Epub 2012 Dec 29. J Community Genet. 2014. PMID: 23275180 Free PMC article.
-
Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer.Diabetologia. 2005 Feb;48(2):242-50. doi: 10.1007/s00125-004-1629-7. Epub 2005 Jan 20. Diabetologia. 2005. PMID: 15660263
-
Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD010849. doi: 10.1002/14651858.CD010849.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2018 Mar 14;3:CD010849. doi: 10.1002/14651858.CD010849.pub3. PMID: 26264938 Free PMC article. Updated.
-
Costs, effects, and savings of screening for cystic fibrosis gene carriers.J Epidemiol Community Health. 1998 Jul;52(7):459-67. doi: 10.1136/jech.52.7.459. J Epidemiol Community Health. 1998. PMID: 9799881 Free PMC article.
-
Direct marketing of cystic fibrosis carrier screening: commercial push or population need?J Med Genet. 1995 Apr;32(4):249-50. doi: 10.1136/jmg.32.4.249. J Med Genet. 1995. PMID: 7643350 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical